Skip to main content
Clinical Trials/IRCT201303301030N13
IRCT201303301030N13
Completed
Phase 2

The effect of N-acetyl cysteine in preventing the incidence and severity of mucositis in patients undergoing bone marrow transplantation

Hematology Oncology and SCT Research Center0 sites64 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Condition 1: Mucositis (oral). Condition 2: AML. Condition 3: ALL. Condition 4: MDS.
Sponsor
Hematology Oncology and SCT Research Center
Enrollment
64
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Hematology Oncology and SCT Research Center

Eligibility Criteria

Inclusion Criteria

  • 1\- Patients receiving chemotherapy regimens (Endoxane\- busulfan) in bone marrow transplantation.
  • 2\- The patient over the 18 years old of age.
  • 3\-Informed consent forms signed by the patients.
  • 1\- Participating in other clinical trial (drug or supplement)
  • 2\- Dissatisfaction of patient.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials